Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Other Operating Expenses (2020 - 2025)

iSpecimen has reported Other Operating Expenses over the past 6 years, most recently at $7.8 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $7.8 million for Q4 2025, up 906.69% from a year ago — trailing twelve months through Dec 2025 was $11.7 million (up 205.94% YoY), and the annual figure for FY2025 was $5.3 million, up 231.8%.
  • Other Operating Expenses for Q4 2025 was $7.8 million at iSpecimen, up from $1.5 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for ISPC hit a ceiling of $7.8 million in Q4 2025 and a floor of -$12.2 million in Q4 2023.
  • Median Other Operating Expenses over the past 5 years was $2.5 million (2021), compared with a mean of $1.6 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 499.15% in 2023 and later skyrocketed 906.69% in 2025.
  • iSpecimen's Other Operating Expenses stood at $2.6 million in 2021, then grew by 19.48% to $3.1 million in 2022, then plummeted by 499.15% to -$12.2 million in 2023, then skyrocketed by 92.09% to -$962951.0 in 2024, then skyrocketed by 906.69% to $7.8 million in 2025.
  • The last three reported values for Other Operating Expenses were $7.8 million (Q4 2025), $1.5 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.